The National Stock Exchange of India's long-awaited initial public offering, structured as a pure offer-for-sale raising over ₹20,000 crore, presents a transformative opportunity for three state-run general insurers. National Insurance Company, Oriental Insurance Company, and United India Insurance Company together hold approximately 75 million shares in the exchange. At a conservative listing price of ₹1,500 per share, these holdings translate to roughly ₹11,500-12,000 crore in value—or about ₹4,500 crore per insurer. This capital unlock could improve their solvency ratios by nearly 100 basis points, effectively equivalent to a government capital infusion of similar scale.
The mechanics of this value unlock are straightforward yet powerful. Currently, the insurers carry their NSE stakes at conservative valuations on their balance sheets due to the exchange's unlisted status. Once NSE lists publicly, these holdings can be marked to market, immediately boosting the insurers' net worth and available solvency margin. Since the IPO is structured entirely as an offer-for-sale, existing shareholders like the PSU insurers will receive the proceeds directly, rather than the exchange raising fresh equity. This creates capital gains without dilution for NSE itself.
The solvency improvement is urgently needed. As of March 2025, all three insurers operate deeply below the IRDAI regulatory mandate of 1.5 times required solvency margin. National Insurance reported a solvency ratio of -0.67, Oriental Insurance stood at -1.03, and United India Insurance at -0.65. This negative territory means their liabilities exceed their available capital, a precarious position that has persisted for over 20 consecutive quarters. The deterioration from June 2024 levels—when National Insurance was at -0.46 and United India at -0.73—reflects sustained balance sheet stress driven primarily by weak underwriting performance.
Rating agency ICRA estimates that these three insurers collectively require ₹15,200-17,000 crore to achieve the 1.50x solvency threshold by March 2026, assuming 100% forbearance on the Fair Value Change Account. The NSE IPO's ₹12,000 crore unlock addresses approximately 70-79% of this requirement, a substantial portion but not a complete solution. The government is separately considering a ₹5,000 crore capital infusion, which combined with the NSE proceeds could fully address the capital gap. However, historical context is sobering: the government has previously infused ₹17,450 crore across FY2020-22 without achieving sustained recovery, indicating that capital alone is insufficient without structural reforms.
The root causes of the solvency crisis lie in chronic underwriting losses and operational inefficiencies. National Insurance's combined ratio stood at 126.9% in FY2024, while United India reported 125.7%. A combined ratio above 100% means the insurer loses money on core insurance operations before investment income. The underwriting deficits are staggering—National Insurance reported an underwriting deficit of ₹3,686 crore in FY2024, partially offset by investment income of ₹3,315 crore. United Insurance's net worth has turned negative at ₹1,528 crore as of December 2024.
The operational challenges are systemic. A Comptroller and Auditor General report revealed that all four PSU insurers incurred aggregate losses of ₹26,364 crore in health insurance during 2016-17 to 2020-21. The audit identified non-adherence to underwriting policies, undercharging of premium by ₹1,548 crore in 155 group health policies, and combined ratios in group health segments ranging from 125-165%, violating Ministry of Finance guidelines requiring ratios below 100%. Third-party administrator management was equally problematic, with major business allocated to TPAs despite high claims ratios above 100%, and inadequate safeguards leading to fraudulent activities.
The contrast with New India Assurance, the only listed and financially healthy PSU general insurer, is instructive. New India maintains a solvency ratio of approximately 1.9x, comfortably above regulatory norms, despite facing similar market challenges. The company's net worth stands at ₹22,630 crore, with a substantial ₹19,993 crore balance in its fair value change account. While New India's underwriting performance is also modest—combined ratio of 116.8% in FY2025—it has never sought government capital infusion and aspires to continue operating without external capital raising.
The strategic differences are revealing. New India operates with an expense ratio in the early 20% range, well below the regulatory cap of 30%, and consciously avoids using this headroom for aggressive commission-led growth. The company focuses on "growth with profitability," backed by better risk selection, balance sheet cleanup, and underwriting discipline. In contrast, the other three PSU insurers struggle with expense ratios around 28%, limited digital capabilities, and systemic underwriting weaknesses. New India also benefits from international operations across 24 countries, providing geographic diversification that its domestic-focused peers lack.
The decision to monetize NSE stakes presents a strategic dilemma for the three insurers. Selling shares provides immediate solvency improvement—approximately 100 basis points per insurer—but foregoes potential long-term capital appreciation from holding a strategic stake in India's largest stock exchange. NSE, as a near-monopoly in equity markets, offers significant growth potential as India's financialization story unfolds. However, the immediate solvency crisis may necessitate at least partial monetization. A phased approach—selling 30-40% initially for regulatory compliance, then evaluating the remainder based on post-listing performance—could optimally balance these competing priorities.
The improved solvency from NSE IPO proceeds would enhance the insurers' ability to underwrite new business and compete with private sector insurers. Currently, their negative solvency positions severely constrain business growth, while private insurers are projected to expand their market share to 70% by FY2027. With positive solvency, the PSU insurers could rebuild their presence in growth segments like health insurance, expand broker relationships, and invest in digital transformation. However, sustainable competitiveness requires more than capital—it demands operational restructuring, expense ratio reduction to the early 20% range, and implementation of sophisticated underwriting and claims management systems.
The NSE IPO represents a critical turning point for these three insurers, but it is not a panacea. The ₹12,000 crore unlock provides essential breathing room to address immediate solvency concerns, but sustainable recovery requires comprehensive structural reforms. The insurers must use this capital not merely to patch balance sheets, but to fund the operational transformation needed to achieve profitable underwriting, reduce combined ratios below 100%, and rebuild their competitive position in India's evolving insurance market. Without such reforms, future capital infusions will likely prove as temporary as previous government bailouts.
